[1]
2020. Impact of a Prognostic 40-Gene Expression Profiling Test on Clinical Management Decisions for High-Risk Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s64. DOI:https://doi.org/10.25251/skin.4.supp.63.